Updated just now · Live
Johnson & Johnson researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company operates through its Innovative Medicine and MedTech segments following the spinoff of its consumer health division.
Johnson & Johnson operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for JNJ.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). JNJ Stock Intelligence Report. [stoxpulse.com/stocks/jnj]
Disclaimer: The information on this page about Johnson & Johnson (JNJ) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Johnson & Johnson.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 1%
Jun 30
Wengel bought 10K shares
Jun 11
Wengel sold 10K shares
Jun 11
Johnson & Johnson vs Abbott Laboratories: Two Heal...
1h ago
HALO Inks Deal With INCY to Support Cancer Therapy...
2h ago
StoxPulse AI results for JNJ: Pulse Score 54/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$598.96B
P/E Ratio
18.8
EPS
$2.10
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+0.5%
Dec 25
-0.1%
Mar 26
+0.3%
Jun 26
+0.9%
Beat estimates 3 of 4 quarters (75%)
Johnson & Johnson researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company operates through its Innovative Medicine and MedTech segments following the spinoff of its consumer health division.
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories
HALO Inks Deal With INCY to Support Cancer Therapy Development
70 Dividend Aristocrats Face Their Mid-2026 Test: NOBL’s 2% Yield Under Pressure
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth
The Zacks Analyst Blog Highlights Johnson & Johnson, Lam Research, Seagate, KVH Industries and Dawson Geophysical
Straight Out Of A Soap Opera: Biotech Exec Arrested After 21 Years On The Run
Top Analyst Reports for Johnson & Johnson, Lam Research & Seagate
The Robot Maker's Paradox